𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment with selegiline in Alzheimer's disease — SPECT evaluations

✍ Scribed by M.D. Gheorghe; G. Grigorescu

Book ID
118601610
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
145 KB
Volume
9
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SELEGILINE IN THE TREATMENT OF BEHAVIOUR
SELEGILINE IN THE TREATMENT OF BEHAVIOURAL DISTURBANCE IN ALZHEIMER'S DISEASE
✍ BRIAN A. LAWLOR; PAUL S. AISEN; CYNTHIA GREEN; ELIZABETH FINE; JAMES SCHMEIDLER 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Objective. The purpose of this study was to examine the behavioural and cognitive eects of selegiline in a group of moderately behaviourally disturbed AD patients. Design. This was a 14-week randomized double-blind placebo-controlled study of selegiline (10 mg) and placebo. Setting. An outpatient

Correlation of neuropsychological evalua
Correlation of neuropsychological evaluation and SPECT imaging in patients with Alzheimer's disease
✍ Yair Lampl; Menahem Sadeh; Olga Laker; Mordechai Lorberboym 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 1 views

## Abstract ## Background Mini‐Mental State Examination (MMSE) is a very useful tool for diagnosing changes in cognitive functions by the general practitioner or other medical staff who is not familiar with neuropsychological tests. On the other hand, HMPAO brain SPECT has been shown to have a hig